D-1 Dopamine Receptors Mediate Dopamine-Induced Pancreatic Exocrine Secretion in Anesthetized Dogs

  • Iwatsuki Kazuhiko
    the Department of Pharmacology, Shinshu University School of Medicine
  • Horiuchi Akira
    the Department of Pharmacology, Shinshu University School of Medicine
  • Ren Lei-Ming
    the Department of Pharmacology, Shinshu University School of Medicine
  • Chiba Shigetoshi
    the Department of Pharmacology, Shinshu University School of Medicine

Search this article

Abstract

Characterization of dopamine (DA) receptor subtypes was examined on the canine exocrine pancreas using selective DA receptor agonists and antagonists in anesthetized dogs. Each drug was injected i.a. in a single bolus fashion. Graded doses of DA (0.01-3μmol) produced dose-dependent increases in the secretory rate of pancreatic juice, with a maximum effect at approximately 1μmol. SCH23390 (3-30nmol), a selective D-1 DA receptor antagonist, caused a progressive parallel shift to the right in the dose-response curve for DA-induced pancreatic secretion without changes in the maximal response. However, domperidone (3μmol), a selective D-2 DA receptor antagonist, did not antagonize the DA-induced pancreatic exocrine secretion. A Schild analysis of the data indicates that the inhibitory constant value for SCH23390 to inhibit DA-stimulated secretion was 6.9nmol. In addition, the stimulatory effects of SKF38393 (0.1-10μmol) and YM435 (0.3-30nmol), selective D-1 DA receptor agonists, and LY171555 (1-10μmol), a selective D-2 DA receptor agonist, on pancreatic secretion were demonstrated. The rank order of agonist potency was YM435>DA>SKF38393_??_LY171555. These results suggest that DA-induced pancreatic exocrine secretion is mediated by activation of D-1 DA receptors. (Hypertens Res 1995; 18 Suppl. I: S173-S174)

Journal

  • Hypertension Research

    Hypertension Research 18 (SupplementI), S173-S174, 1995

    The Japanese Society of Hypertension

References(3)*help

See more

Details 詳細情報について

Report a problem

Back to top